Results 111 to 120 of about 828,584 (305)

An Analysis of the Third Government Report on the Benefits and Costs of Federal Regulations [PDF]

open access: yes
This paper critically reviews the draft of the Office of Management and Budget's third report on the benefits and costs of federal regulation. The purpose of this analysis is to offer constructive recommendations for improving that report.
Hahn, Robert W., Litan, Robert E.
core  

Association Between Neurofilament Light Chain and Real‐World Ambulatory Function in Progressive MS

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neurofilament light chain (NfL) is a biomarker of neuroaxonal injury in multiple sclerosis (MS), yet associations with functional outcomes remain unclear. Longitudinal associations between serum NfL (sNfL) and daily step count (STEPS) from wearable devices were assessed in a large international progressive MS cohort.
Gabby B. Joseph   +5 more
wiley   +1 more source

Snuff in Colombia: costs and what benefits?

open access: yesCivilizar, 2013
This document analyzes the cost on the health system snuff consumption and compared these with the benefits obtained as employment and tax revenues in the period 1973-2008, this analysis is done from the estimation of quantitative by simple regression ...
Alex Smith Araque Solano
doaj  

A Qualitative Assessment of the Benefits and Costs of On-Farm Food Safety and Environmental Farm Plans in the Dairy Sector [PDF]

open access: yes
This series of six reports entitled: "On-Farm Food Safety and Environmental Farm Plans: Identifying and Classifying Benefits and Costs" was initiated soon after the launch of the Agricultural Policy Framework (APF) in 2002.
Gervais, Jean-Philippe   +4 more
core  

Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are a relatively new class of drugs that were initially approved by the US Food and Drug Administration to improve glycemic control in patients with type 2 diabetes mellitus and, subsequently, weight reduction in patients with obesity.
Audrey Y. Chang, Farrah J. Mateen
wiley   +1 more source

Price Stability vs. Low Inflation in Germany: An Analysis of Costs and Benefits [PDF]

open access: yes
We empirically investigate the costs and benefits of going from low inflation to price stability in the case of Germany. Recent empirical evidence on the sacrifice ratio suggests that the break-even point at which the permanent benefits of reducing the ...
Karl-Heinz Todter, Gerhard Ziebarth
core  

A Two‐Stage Plasma Biomarker Algorithm Reduces Amyloid PET Use and the p‐Tau217 Gray Zone

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Plasma p‐Tau217 leaves 30%–50% of patients in an indeterminate “gray zone” often requiring Aβ‐PET. We developed GRAD (Gatekeeper‐Reflex for Alzheimer's Disease), a two‐stage Aβ‐positivity prediction model to improve classification while reserving Aβ‐PET for residual uncertainty.
Harthik Parankusham   +7 more
wiley   +1 more source

First and second pillar pensions: costs and benefits for contributors in the Baltics

open access: yesBaltic Journal of Economics
Early in the twenty-first century, the Baltic states reformed their retirement pension systems by introducing funded pensions (second and third pillars) alongside the existing pay-as-you-go (PAYG) system.
Tadas Gudaitis   +3 more
doaj   +1 more source

An Analysis of the Ninth Government Report on the Costs and Benefits of Federal Regulations [PDF]

open access: yes
This paper critically reviews the draft of the Office of Management and Budget's ninth report on the benefits and costs of federal regulation. The draft report is similar to previous reports, and does not break new ground. We offer seven recommendations,
Hahn, Robert W., Litan, Robert E.
core  

Transport costs do not negate the benefits of agricultural carbon mitigation options

open access: yes, 2000
It has been suggested that some agricultural carbon (C) mitigation options will yield no net C benefit under full carbon accounting (i.e. when costs are included alongside benefits). The largest likely C cost of implementing many options is the fuel cost
Smith, P., Smith, T. J. F., Smith, Pete
core   +1 more source

Home - About - Disclaimer - Privacy